Dr. Edward Darnell Clemons Jr. is a pharmacist who is specialized in Pharmacotherapy in Tallahassee, Florida. Patients can reach him at 1300 Miccosukee Rd, Tallahassee or contact him on 850-431-4389. Active license number of Dr. Edward Darnell Clemons Jr. is PS47817 for Pharmacotherapy in Florida. Dr. Edward Darnell Clemons Jr. is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Edward Darnell Clemons Jr. speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Edward Darnell Clemons Jr. are as mentioned below.
NPI Number:
1902163470
NPI Enumeration Date:
20 Apr, 2012
NPI Last Update On:
20 Apr, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Edward Darnell Clemons Jr. are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PS47817
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1300 Miccosukee Rd, Tallahassee, Florida
Zip:
32308-5054
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Edward Darnell Clemons Jr. at 1300 Miccosukee Rd, Tallahassee, Florida or can call on phone at 850-431-4389.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.